Jeremy R. Graff's most recent trade in IN8bio Inc was a trade of 63,150 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IN8bio Inc | Jeremy R. Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 63,150 | 63,150 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Jeremy R. Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 2,049 | 2,049 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Jeremy R. Graff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 2,049 | 0 | - | - | Series B Warrants (right to buy) | |
| Allarity Therapeutics Inc | Jeremy Graff R. | CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 144,441 | 262,924 | - | 0 | Common Stock |